Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Gujarat Ambuja Exports Limited (GAEL.NS)
Ahmedabad, IN
Gujarat Ambuja Exports Limited, established in Ahmedabad, India, in 1986, is primarily engaged in a broad spectrum of agro-processing activities for both the Indian and international markets. The company strategically organizes its diverse operations into key segments: Agro, Cotton, Maize, Power, and Other. Its extensive product offerings include textile-grade cotton yarns and various wheat-processed goods. GAEL manufactures a range of polyols such as sorbitol, maltitol, and mannitol. Within the edible oils and fats category, their portfolio encompasses bakery shortenings, along with refined oils derived from cottonseed, corn, groundnut, palm, and soybean, as well as vanaspati ghee. Furthermore, the company supplies a variety of soy products, including flour, flakes, grits, liquid lecithin, and granules/nuggets. For the animal nutrition sector, they provide essential feed ingredients like corn/maize gluten, rapeseed extraction, soybean meals, and complete cattle feed formulations. A significant portion of their business also involves starch derivatives, featuring products such as high maltose corn syrup, dextrose syrup, corn steep liquor, corn gluten meal, maize germ, malto dextrin powder, various dextrins, anhydrous and monohydrate dextrose powders, maltose syrup, liquid glucose, maize and corn starch, and liquid sorbitol solution. Beyond its core agro-processing, Gujarat Ambuja Exports is actively involved in power generation, utilizing diverse sources like windmills, biogas, and solar energy, alongside thermal plants. The company's wide array of products and services supports a multitude of industries, including textile, paper, food, feed, cosmetics, pharmaceutical, and animal nutrition.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.60% | -6.67% | +9.80% | +17.54% | +57.46% | +18.10% | +40.56% | +38.87% | +88.41% | +1,077.64% | +35,866.85% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+24.2% ★ Q1'26: +15.8% (vs Q1'25)
-
EPS growth Packaged Foods: +14.6%+21.9% ★ Q1'26: +321.4% (vs Q1'25)
-
FCF margin FCF growth · Packaged Foods: +15.9%+0.8% Q1'26: -4.7% (vs Q1'25)
-
EBIT margin Packaged Foods: +7.9%+5.7% Q1'26: +11.0% (vs Q1'25)
-
ROIC Packaged Foods: +7.0%+8.6% ★ Q1'26: +16.9% (vs Q1'25)
-
Share dilution Packaged Foods: +0.0%+0.1% Q1'26: +0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.95× ★ Q1'26: 0.57× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
30.16B
est: 33.45B (-9.9%)
|
30.92B
est: 32.27B (-4.2%)
|
25.31B
est: 35.25B (-28.2%)
|
27.36B
est: 38.77B (-29.4%)
|
33.31B
est: 30.51B (+9.2%)
|
33.29B
est: 34.60B (-3.8%)
|
40.21B
est: 38.43B (+4.6%)
|
38.17B
est: 40.75B (-6.3%)
|
47.05B
est: 41.58B (+13.2%)
|
46.70B
est: 46.50B (+0.4%)
|
49.09B
est: 65.83B (-25.4%)
|
49.27B
est: 48.54B (+1.5%)
|
46.13B
est: 50.53B (-8.7%)
|
50.11B
50.11B – 50.11B
-0.8% YoY
|
61.98B
61.98B – 61.98B
+23.7% YoY
|
76.37B
76.37B – 76.37B
+23.2% YoY
|
| EBITDA |
1.97B
est: 3.99B (-50.6%)
|
2.05B
est: 3.77B (-45.7%)
|
1.74B
est: 4.20B (-58.7%)
|
1.98B
est: 4.62B (-57.2%)
|
2.97B
est: 3.64B (-18.5%)
|
3.26B
est: 1.65B (+97.7%)
|
3.78B
est: 3.07B (+23.0%)
|
2.87B
est: 4.86B (-41.0%)
|
5.61B
est: 4.96B (+13.3%)
|
7.41B
est: 5.54B (+33.7%)
|
5.49B
est: 7.85B (-30.0%)
|
5.87B
est: 5.42B (+8.4%)
|
4.01B
est: 5.64B (-28.9%)
|
5.59B
5.59B – 5.59B
-0.8% YoY
|
6.92B
6.92B – 6.92B
+23.7% YoY
|
8.52B
8.52B – 8.52B
+23.2% YoY
|
| EBIT |
1.49B
est: 3.23B (-53.9%)
|
1.54B
est: 3.05B (-49.6%)
|
1.10B
est: 3.40B (-67.6%)
|
1.33B
est: 3.74B (-64.5%)
|
2.17B
est: 2.94B (-26.1%)
|
2.46B
est: 1.22B (+101.8%)
|
2.82B
est: 2.47B (+14.1%)
|
1.86B
est: 3.93B (-52.7%)
|
4.58B
est: 4.01B (+14.3%)
|
6.44B
est: 4.48B (+43.6%)
|
4.54B
est: 6.35B (-28.4%)
|
4.66B
est: 4.29B (+8.6%)
|
2.75B
est: 4.47B (-38.4%)
|
4.43B
4.43B – 4.43B
-0.8% YoY
|
5.48B
5.48B – 5.48B
+23.7% YoY
|
6.75B
6.75B – 6.75B
+23.2% YoY
|
| Net Income |
1.13B
est: 4.41B (-74.4%)
|
1.11B
est: 3.07B (-63.7%)
|
840.90M
est: 1.08B (-21.8%)
|
1.04B
est: 1.18B (-12.3%)
|
1.59B
est: 1.43B (+10.7%)
|
1.80B
est: 942.94M (+90.8%)
|
1.98B
est: 1.84B (+7.6%)
|
1.46B
est: 1.40B (+4.3%)
|
3.38B
est: 2.96B (+14.4%)
|
4.75B
est: 4.10B (+15.9%)
|
3.30B
est: 5.02B (-34.2%)
|
3.46B
est: 3.51B (-1.6%)
|
2.49B
est: 3.44B (-27.6%)
|
2.02B
2.02B – 2.02B
-41.3% YoY
|
4.27B
4.27B – 4.27B
+111.4% YoY
|
5.46B
5.46B – 5.46B
+28.0% YoY
|
| SGA |
1.43B
est: 1.39B (+3.3%)
|
1.72B
est: 1.31B (+30.9%)
|
805.80M
est: 1.46B (-44.8%)
|
779.20M
est: 1.61B (-51.5%)
|
902.80M
est: 1.26B (-28.6%)
|
1.21B
est: 2.02B (-40.1%)
|
1.57B
est: 2.64B (-40.5%)
|
991.70M
est: 1.69B (-41.3%)
|
2.04B
est: 1.72B (+18.5%)
|
2.03B
est: 1.93B (+5.1%)
|
2.25B
est: 2.73B (-17.7%)
|
2.25B
est: 3.05B (-26.3%)
|
1.34B
est: 3.18B (-57.8%)
|
3.15B
3.15B – 3.15B
-0.8% YoY
|
3.90B
3.90B – 3.90B
+23.7% YoY
|
4.80B
4.80B – 4.80B
+23.2% YoY
|
| EPS |
4.08
est: 9.62 (-57.6%)
|
3.03
est: 6.72 (-54.9%)
|
3.04
est: 2.35 (+29.5%)
|
3.63
est: 2.58 (+40.7%)
|
5.75
est: 3.13 (+84.0%)
|
7.84
est: 3.83 (+104.5%)
|
8.64
est: 4.90 (+76.4%)
|
8.48
est: 3.05 (+178.0%)
|
7.37
est: 6.45 (+14.3%)
|
10.37
est: 8.95 (+15.9%)
|
7.20
est: 10.95 (-34.2%)
|
7.54
est: 7.66 (-1.5%)
|
5.44
est: 7.50 (-27.5%)
|
4.40
4.40 – 4.40
-41.3% YoY
|
9.30
9.30 – 9.30
+111.4% YoY
|
11.90
11.90 – 11.90
+28.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Manish Vijaykumar Gupta | MD & Chairman | 378M | male |
| Sandeep N. Agrawal | Whole Time Director | 9M | male |
| Giridhar Nagaraj | Chief Financial Officer | — | male |
| Basu Tibrewala | Chief Executive | — | male |
| Shreyaan Manish Gupta | Additional Whole-Time Director | — | male |
| Kalpesh Dave | Company Secretary & Compliance Officer | — | male |
| Brijmohan Chitlange | President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GAEL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
